Aurora A kinase activates YAP signaling in triple-negative breast cancer

被引：0
|
作者：
S-S Chang
H Yamaguchi
W Xia
S-O Lim
Y Khotskaya
Y Wu
W-C Chang
Q Liu
M-C Hung
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Molecular and Cellular Oncology
[2] Cancer Biology Program,Department of Breast Medical Oncology
[3] The University of Texas Graduate School of Biomedical Sciences at Houston,Department of Biotechnology
[4] Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy,undefined
[5] The University of Texas MD Anderson Cancer Center,undefined
[6] The University of Texas MD Anderson Cancer Center,undefined
[7] Center for Molecular Medicine and Graduate Institute of Cancer Biology,undefined
[8] China Medical University,undefined
[9] Sun Yat-Sen University Cancer Center,undefined
[10] State Key Laboratory of Oncology in South China,undefined
[11] Collaborative Innovation Center of Cancer Medicine,undefined
[12] Institute of Cancer Stem Cell,undefined
[13] First Affiliated Hospital Collaborative Innovation Center of Oncology,undefined
[14] Dalian Medical University,undefined
[15] Asia University,undefined
来源：
Oncogene | 2017年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Yes-associated protein (YAP) is an effector that transduces the output of the Hippo pathway to transcriptional modulation. Considering the role of YAP in cancers, this protein has emerged as a key node in malignancy development. In this study, we determined that Aurora A kinase acts as a positive regulator for YAP-mediated transcriptional machinery. Specifically, YAP associates with Aurora A predominantly in the nucleus. Activation of Aurora A can impinge on YAP activity through direct phosphorylation. Moreover, aberrant expression of YAP and Aurora A signaling is highly correlated with triple-negative breast cancer (TNBC). We herein provide evidence to establish the functional relevance of this newly discovered regulatory axis in TNBC.
引用
收藏
页码：1265 / 1275
页数：10
相关论文
共 50 条
  • [1] Aurora A kinase activates YAP signaling in triple-negative breast cancer
    Chang, S-S
    Yamaguchi, H.
    Xia, W.
    Lim, S-O
    Khotskaya, Y.
    Wu, Y.
    Chang, W-C
    Liu, Q.
    Hung, M-C
    [J]. ONCOGENE, 2017, 36 (09) : 1265 - 1275
  • [2] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [3] Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
    Jalalirad, Mohammad
    Haddad, Tufia C.
    Salisbury, Jeffrey L.
    Radisky, Derek
    Zhang, Minzhi
    Schroeder, Mark
    Tuma, Ann
    Leof, Eduard
    Carter, Jodi M.
    Degnim, Amy C.
    Boughey, Judy C.
    Sarkaria, Jann
    Yu, Jia
    Wang, Liewei
    Liu, Minetta C.
    Zammataro, Luca
    Malatino, Lorenzo
    Galanis, Evanthia
    Ingle, James N.
    Goetz, Matthew P.
    D'Assoro, Antonino B.
    [J]. ONCOGENE, 2021, 40 (14) : 2509 - 2523
  • [4] Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
    Mohammad Jalalirad
    Tufia C. Haddad
    Jeffrey L. Salisbury
    Derek Radisky
    Minzhi Zhang
    Mark Schroeder
    Ann Tuma
    Eduard Leof
    Jodi M. Carter
    Amy C. Degnim
    Judy C. Boughey
    Jann Sarkaria
    Jia Yu
    Liewei Wang
    Minetta C. Liu
    Luca Zammataro
    Lorenzo Malatino
    Evanthia Galanis
    James N. Ingle
    Matthew P. Goetz
    Antonino B. D’Assoro
    [J]. Oncogene, 2021, 40 : 2509 - 2523
  • [5] Wnt signaling in triple-negative breast cancer
    Pohl, SO-G
    Brook, N.
    Agostino, M.
    Arfuso, F.
    Kumar, A. P.
    Dharmarajan, A.
    [J]. ONCOGENESIS, 2017, 6 : e310 - e310
  • [6] Wnt signaling in triple-negative breast cancer
    SÖ-G Pohl
    N Brook
    M Agostino
    F Arfuso
    A P Kumar
    A Dharmarajan
    [J]. Oncogenesis, 2017, 6 : e310 - e310
  • [7] Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
    Skov, Natascha
    Alves, Carla L.
    Ehmsen, Sidse
    Ditzel, Henrik J.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [8] Novel synergy of radiosensitizer prodrug IPdR with Aurora kinase inhibitors in triple-negative breast cancer
    Rampurwala, Murtuza M.
    Choudhary, Alka
    Burkard, Mark E.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [9] Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer
    Acharya, Sunil
    Yao, Jun
    Li, Ping
    Zhang, Chenyu
    Lowery, Frank J.
    Zhang, Qingling
    Guo, Hua
    Qu, Jingkun
    Yang, Fei
    Wistuba, Ignacio I.
    Piwnica-Worms, Helen
    Sahin, Aysegul A.
    Yu, Dihua
    [J]. CANCER RESEARCH, 2019, 79 (16) : 4211 - 4226
  • [10] Rational combination of mTOR and Aurora kinase A inhibition in preclinical models of triple-negative breast cancer
    Diamond, Jennifer R.
    Orth, James D.
    Ionkina, Anastasia
    Dailey, Kyrie
    Pitts, Todd M.
    Capasso, Anna
    Marcus, Joshua M.
    Burke, Russell T.
    Davis, Sarah L.
    Kim, Jiyhe
    Tan, Aik-Choon
    Eckhardt, Sue G.
    Tentler, John J.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345